Gene-editing paves way for new Alzheimer’s treatments.

Gene-editing paves way for new Alzheimer's treatments.

Potential New Treatments for Alzheimer’s Disease Offer Hope

Alzheimer’s disease is a devastating condition affecting millions of people worldwide. However, recent studies utilizing CRISPR gene editing have brought a glimmer of hope to the Alzheimer’s and dementia community. The Alzheimer’s Association’s Chief Science Officer, Maria Carrillo, emphasizes that the progress made in the development of potential new therapies is cause for optimism. She notes that while the recent approval of anti-amyloid drugs by the U.S. Food and Drug Administration is a significant advancement, there is still much more that can be done to combat this complex disease.

CRISPR Gene Editing: A Promising Tool

CRISPR, an acronym for Clustered Regularly Interspaced Short Palindromic Repeats, is an advanced gene editing system that holds great potential for identifying effective treatments for Alzheimer’s disease. By using CRISPR, researchers can target specific genes and manipulate them to reduce the risk or progression of the disease. This breakthrough technology has paved the way for innovative studies aimed at advancing Alzheimer’s treatment and prevention.

Targeting the APOE-e4 Gene

One of the studies focuses on the most common Alzheimer’s risk gene, APOE-e4. While inheriting this gene does not guarantee the development of Alzheimer’s, having one copy increases the risk two to threefold, while having two copies increases the risk up to 12 times. The study found that levels of APOE-e4 could be significantly reduced in miniature brains derived from Alzheimer’s patients and in humanized mouse models. Importantly, this reduction in APOE-e4 levels did not affect other APOE variants believed to be neutral or protective. These findings provide strong evidence supporting APOE-e4 as a potential therapeutic target for Alzheimer’s disease.

The Amyloid Precursor Protein (APP) Approach

In another study, researchers developed a gene-editing strategy that targets the amyloid precursor protein (APP). APP plays a central role in Alzheimer’s as it can produce both protective byproducts (sAPPa) and pathologic ones (beta amyloid), depending on how it is cut by various enzymes in the brain. The goal of this approach is to reduce the production of beta amyloid while increasing neuroprotective actions. The researchers found that CRISPR treatment successfully reduced beta amyloid plaque levels and associated markers of brain inflammation. Additionally, it increased the production of neuroprotective APP products and restored behavioral and nervous system function in an Alzheimer’s disease mouse model. Importantly, this gene-editing technique did not result in any undesirable side effects in normal mice, indicating its potential as a safe and effective treatment.

A Future of Precision Medicine

The ultimate aim of these studies is to pave the way for precision medicine in Alzheimer’s treatment. By targeting specific genes such as APOE-e4 and APP, researchers hope to develop personalized therapies that address the unique genetic makeup and characteristics of individuals with Alzheimer’s. The success of these studies opens the door to further research and human testing of these potential treatments.

• Can stretching your brain lower dementia risk as you age?
• Study Concussions do not lower children’s IQ.
• Healthy Summer Backyard Feasts

Hope for a Cure

The presentations of these groundbreaking studies at the Alzheimer’s Association International Conference in Amsterdam have provided a ray of hope for the millions affected by Alzheimer’s disease. While the research is still considered preliminary until published in a peer-reviewed journal, the results are incredibly promising. The steps taken towards finding a cure for Alzheimer’s give renewed hope to patients, caregivers, and the scientific community. As Chief Science Officer Maria Carrillo emphasizes, the vision of a future where multiple treatments address every aspect of this complex disease, ultimately leading to a cure, is becoming an achievable goal.

### SLIDESHOW: The Stages of Dementia: Alzheimer’s Disease and Aging Brains